Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07NKJ
|
|||
| Drug Name |
AT-001
|
|||
| Synonyms |
Aldose reductase-IN-1; 1355612-71-3; AT-001; UNII-E8I3O45DDU; E8I3O45DDU; SCHEMBL359604; CHEMBL4297455; ZINC113653985; DB15121; CS-5128; NCGC00484072-01; HY-18967
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 2 | [1] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H10F3N5O3S
|
|||
| Canonical SMILES |
C1=CC2=C(C=C1C(F)(F)F)N=C(S2)CN3C(=O)C4=NC=CN=C4C(=N3)CC(=O)O
|
|||
| InChI |
1S/C17H10F3N5O3S/c18-17(19,20)8-1-2-11-9(5-8)23-12(29-11)7-25-16(28)15-14(21-3-4-22-15)10(24-25)6-13(26)27/h1-5H,6-7H2,(H,26,27)
|
|||
| InChIKey |
YRGPAXAVTDMKDK-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1355612-71-3
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04365699) Cardiovascular Effects of COVID-19. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.